• Accuracy
iFastBP® delivers high-accuracy blood pressure measurements by using patient-specific algorithms based on real-time analysis of arterial pulse waveforms. Unlike conventional systems, it adapts the calculation method to different patient types, improving accuracy across diverse populations.Its algorithm is trained on a clinical database built by correlating pulse waveforms with reference blood pressure values determined by dual-physician auscultation, ensuring reliable results in critical care settings.
• Intelligent MeasurementiFastBP® integrates intelligent inflation, deflation, and arterial pulse sampling to improve measurement speed, accuracy, and patient comfort. By estimating the target inflation pressure based on the patient's systolic value, the system avoids under- or over-inflation, enabling accurate measurements without repeat cycles—saving time and reducing discomfort.During deflation, the system dynamically adjusts parameters in response to motion artifacts and pulse signal quality, ensuring accurate pulse detection and reducing the risk of measurement failure. This intelligent approach enhances clinical efficiency, minimizes patient discomfort, and reduces staff workload and complaints—especially under motion-prone conditions where traditional systems may fail.
• Broad Clinical ApplicabilityiFastBP® features wide-range signal processing technology, enabling accurate blood pressure measurement across a variety of clinical scenarios—including low perfusion in intensive care and motion interference in neonatal monitoring.As shown in hereafter, iFastBP® maintains high accuracy even under high arterial pulse conditions, which are common in neonates—outperforming general methods in these challenging settings.
As shown in Figure hereafter, it is evident that the iFastBP® system offers clear advantages over conventional methods—particularly in neonatal monitoring, where it more effectively meets simulated clinical conditions.
As shown in Figure hereafter, test results demonstrate that iFastBP® provides greater accuracy and reliability compared to conventional methods. Clinical investigations further confirm a reduction in user complaints with iFastBP®, enhancing overall clinical satisfaction.
Figure below shows comparative clinical feedback from acute and critical care settings, indicating that iFastBP® outperforms conventional blood pressure monitoring technologies, with significantly fewer clinical complaints reported.
• Anti-Motion CapabilityiFastBP® integrates real-time and frequency-domain algorithms that operate in parallel to ensure reliable and accurate blood pressure measurements, even in the presence of motion or noise.
When arterial pulse signals are missing or distorted, the frequency algorithm compensates to reconstruct a complete pulse waveform, enabling accurate pressure determination.This advanced anti-motion feature enhances measurement reliability in challenging scenarios such as bedside monitoring, remote care, spot checks, ambulatory conditions, and neonatal monitoring. Comparative clinical testing shows that iFastBP® consistently outperforms conventional methods, as illustrated below.